Checkpoint Genetics Pharmaceuticals, Inc. Retains Marcala Foundation.Business Editors LOS ANGELES--(BUSINESS WIRE)--July 31, 2001 Checkpoint Genetics Pharmaceuticals, Inc. (Pink Sheets:CKPT CKPT Checkpoint CKPT Cockpit ), a company that is engaged in the development of new drug candidates as specifically well as pharmaceutical and nutritional supplements Nutritional Supplements Definition Nutritional supplements include vitamins, minerals, herbs, meal supplements, sports nutrition products, natural food supplements, and other related products used to boost the nutritional content of the diet. through its subsidiaries, has retained Marcala Foundation a private investment banking advisory firm assets manager of public and investor relations Investor relations The process by which the corporation communicates with its investors. services. ABOUT MARCALA FOUNDATION Marcala Foundation is a private, investment banking firm specializing in meeting the financial needs of small cap and micro cap, publicly traded companies. Marcala offers its clients a wide range of services and access to a full staff of in-house professionals dedicated to supporting growth strategies through research, public relations public relations, activities and policies used to create public interest in a person, idea, product, institution, or business establishment. By its nature, public relations is devoted to serving particular interests by presenting them to the public in the most and marketing. Marcala Foundation maintains offices in Vancouver and London. ABOUT CHECKPOINT GENETICS PHARMACEUTICALS, INC. Checkpoint Genetics Pharmaceuticals, Inc., through its subsidiaries, is engaged in the development, production and distribution of new drug candidates as specifically well as pharmaceutical and nutritional supplements. For more information visit the company website at: www.ckpt-genetics.com The press release contains forward-looking statements made pursuant to the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Expression of future goals and similar expressions reflecting something other than historical fact involve risks and uncertainties. The actual results the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion